Two Sigma Investments’s HCW Biologics HCWB Stock Holding History

Two Sigma Investments’s Portfolio HCWB Stock Details HCWB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50	Closed	-$5.39K	–	3313
2024 Q4	$5.39K	Sell	50 -44	-47%	-$5.13K	﹤0.01%	3146
2024 Q3	$12.1K	Hold	94	–	–	﹤0.01%	3040
2024 Q2	$14.5K	Hold	94	–	–	﹤0.01%	2945
2024 Q1	$39.6K	Hold	94	–	–	﹤0.01%	2893
2023 Q4	$27.7K	Sell	94 -1	-1%	-$341	﹤0.01%	3044
2023 Q3	$43.4K	Sell	95 -16	-14%	-$7.91K	﹤0.01%	2831
2023 Q2	$57.6K	Sell	111 -9	-8%	-$3.58K	﹤0.01%	2811
2023 Q1	$40.3K	Sell	120 -14	-10%	-$6.06K	﹤0.01%	2786
2022 Q4	$61.7K	Sell	134 -25	-16%	-$12.9K	﹤0.01%	2570
2022 Q3	$87K	Sell	159 -6	-4%	-$3.44K	﹤0.01%	2249
2022 Q2	$87K	Sell	165 -48	-23%	-$27K	﹤0.01%	2283
2022 Q1	$140K	Sell	213 -307	-59%	-$164K	﹤0.01%	2390
2021 Q4	$289K	Buy	+520	New	+$353K	﹤0.01%	3670

Other funds holding HCWB

APP

Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

PIM

Pullen Investment Management Bradenton, Florida $216M AUM 32.94% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

Two Sigma Investments's HCWB Position: Q1 2025 in Review

Two Sigma Investments sold out of HCW Biologics (HCWB) in Q1 2025, closing a stake of 50 shares — an estimated $5.39K sold.

Two Sigma Investments first reported a position in HCWB in Q4 2021 and held it in 13 quarters. The position peaked at $289K in Q4 2021. 14 funds tracked by Wall St. Rank hold HCWB as of Q1 2025.

Two Sigma Investments reported no remaining HCW Biologics position as of Q1 2025 after selling out during the quarter.
Two Sigma Investments sold 50 HCW Biologics shares in Q1 2025, an estimated $5.39K.
Two Sigma Investments first reported a position in HCW Biologics in Q4 2021 and held it in 13 quarters.
Two Sigma Investments's HCW Biologics position peaked at $289K in Q4 2021.
14 funds tracked by Wall St. Rank held HCW Biologics as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.